3 completed, 3 unknown, 2 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Peritoneal Fibrosis: new trials by email Literature Review of Peritoneal Fibrosis trials Research Report on Peritoneal Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients Modified Peritoneal Equilibration Test and DKK3 Biomarker Measurement - Peritoneal Dialysis (PD), End Stage Renal Disease (ESRD) | Not yet recruiting | Universität des Saarlandes | 30 | 2026-09-01 | 2026-09-08 | |
| Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis Canagliflozin 300 MG - ESRD, CKD (Chronic Kidney Disease) Stage 5D | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 30 | 2026-02-01 | 2026-03-16 |
| Multi-omics Study of Peritoneal Dialysis Effluent to Explore Biomarkers of Peritoneal Fibrosis Peritoneal Dialysis, Peritoneal Fibrosis | Not yet recruiting | Shanghai Jiao Tong University School of Medicine | 55 | 2025-10-20 | 2025-10-06 | |
| Using New Ultrasound Techniques to Assess Peritoneal Fibrosis in Peritoneal Dialysis Patients Peritoneal Sclerosis | Unknown | Shanghai Jiao Tong University School of Medicine | 210 | 2023-01-01 | 2022-12-15 | |
| Epigenetic Determinants of Peritoneal Fibrosis Peritoneal Fibrosis | Completed | McMaster University | 58 | 2015-09-01 | 2020-03-04 | |
| Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis End Stage Renal Disease | Completed | University of Alabama at Birmingham | 49 | 2014-05-01 | 2017-04-19 | |
| Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients N-acetylcysteine - End-Stage Kidney Disease, Peritoneal Dialysis | Phase 4 | Unknown | Ewha Womans University | 66 | 2010-03-01 | 2010-04-27 |
| Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis spironolactone, Placebo - End Stage Renal Disease | Phase 3 | Completed | Instituto Nacional de Cardiologia Ignacio Chavez | 20 | 2008-07-01 | 2012-10-25 |
| The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate Peritoneal Fibrosis | Unknown | National Taiwan University Hospital | 2007-11-26 |
Kidney Failure, Chronic (5) · Fibrosis (1) · Renal Insufficiency, Chronic (1)
Digestive System Diseases (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Peritoneal Diseases (9) · Fibrosis (8) · Chronic Disease (5) · Disease Attributes (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Renal Insufficiency (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Renal Insufficiency, Chronic (4)
Acetylcysteine (1) · Canagliflozin (1) · Spironolactone (1)
Shanghai Jiao Tong University School of Medicine (2) · Ewha Womans University (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · McMaster University (1) · National Taiwan University Hospital (1) · University of Alabama at Birmingham (1) · Universität des Saarlandes (1)
Canada (2) · China (2) · Germany (1) · Mexico (1) · South Korea (1) · Taiwan (1) · United States (1)
Duk-Hee Kang, MD. PhD. (1) · Eric L Wallace, M.D. (1) · Jenq-Wen Huang, MD (1) · Magdalena Madero, M.D (1) · Peter J Margetts, MD PhD (1) · Thomas A. Mavrakanas, MD, MSc. (1)
2025 (1)